SCHEMBL5016889

SCHEMBL5016889

O=C1C=C(Nc2ccc(O)cc2)C(Nc2ccc(O)cc2)=CC1=Nc1ccc(O)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
DNM1 Q05193 1/20 0.61
RAB9A P51151 7/20 0.49
BLM P54132 5/20 0.49
MAPT P10636 5/20 0.49
MAPK1 P28482 4/20 0.49
TDP1 Q9NUW8 2/20 0.49
JAK2 O60674 1/20 0.49
EPHB2 P29323 1/20 0.49
CDK4 P11802 1/20 0.41
APAF1 O14727 4/20 0.39
L3MBTL1 Q9Y468 4/20 0.39
NPC1 O15118 6/20 0.38
MEN1 O00255 5/20 0.38
KMT2A Q03164 5/20 0.38
LMNA P02545 3/20 0.38
TDP2 O95551 3/20 0.38
HTT P42858 3/20 0.38
HSP90AA1 P07900 2/20 0.38
NPSR1 Q6W5P4 2/20 0.38
ALDH1A1 P00352 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5016886 1.00 DNM1 (0.61) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15020041 0.89 DNM1 (0.69) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15020045 0.89 DNM1 (0.69) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15039495 0.89 DNM1 (0.69) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15022708 0.84 DNM1 (0.62) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15022710 0.84 DNM1 (0.62) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15039490 0.84 DNM1 (0.61) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15039538 0.84 DNM1 (0.61) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15020365 0.84 DNM1 (0.61) DNM1RAB9ABLMMAPTMAPK1
SCHEMBL15020366 0.84 DNM1 (0.61) DNM1RAB9ABLMMAPTMAPK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-115468994-A Porous nanogold sensor 嘉兴学院 2022-12-13 CN disclosed
US-7449584-B2 N-(2((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide Crystalline Form 1 ABBOTT LABORATORIES INC. (US) 2008-11-11 US disclosed
US-7446206-B2 N-((2Z)-2-((4-hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide crystalline form 2 ABBOTT LABORATORIES INC. (US) 2008-11-04 US disclosed
US-20070099967-A1 causing nucleation in mixture with solvent between about 60 degrees C. and 100 degrees C., supersaturated; and isolating Crystalline Form 1 ABBVIE INC. 2007-05-03 US disclosed
US-20070021470-A1 Crystalline N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide methanolates ABBOTTLABORATORIES 2007-01-25 US disclosed
US-20070021471-A1 Crystalline N-(2-((4-Hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide ethanolates ABBOTT LABORATORIES 2007-01-25 US disclosed
US-20070004782-A1 N-((2Z)-2-((4-Hydroxyphenyl) amino)-1,2-dihydro-3-pyridinyl)-4-methoxybenzenesulfonamide Crystalline Form 2 ABBVIE INC. 2007-01-04 US disclosed
US-20060293367-A1 Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide ABBOTT LABORATORIES 2006-12-28 US disclosed
US-20060293368-A1 Amorphous N-(2-((4-hydroxyphenyl)amino)pyridin-3-yl)-4-methoxybenzenesulfonamide hydrochloride ABBOTT LABORATORIES 2006-12-28 US disclosed